Intérêt du facteur VII activé recombinant dans l’hémorragie de la délivrance sévère réfractaire à la prise en charge conservatrice conventionnelle

[1]  P. Fontana,et al.  Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature , 2004, BJOG : an international journal of obstetrics and gynaecology.

[2]  L. Gerigk,et al.  Cerebral sinus thrombosis in a trauma patient after recombinant activated factor VII infusion. , 2004, Anesthesiology.

[3]  R. Blumenthal,et al.  Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa) , 2003, Archives of Gynecology and Obstetrics.

[4]  H. V. van Geijn,et al.  Successful Treatment of Life‐Threatening Postpartum Hemorrhage With Recombinant Activated Factor VII , 2003, Obstetrics and gynecology.

[5]  K. Kurth,et al.  Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial , 2003, The Lancet.

[6]  J. Murkin.  A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice. , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[7]  E. Segal,et al.  Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[8]  D. Monroe,et al.  Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage. , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[9]  S. Zupančić šalek,et al.  Successful Use of Recombinant Factor VIIa for Massive Bleeding after Caesarean Section due to HELLP Syndrome , 2002, Acta Haematologica.

[10]  W. Hurford,et al.  NO-body's perfect. , 2002, Anesthesiology.

[11]  I. Nováková,et al.  Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia. , 2002, Anesthesiology.

[12]  G. Bręborowicz,et al.  [Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy]. , 2002, Ginekologia polska.

[13]  M. Sanz,et al.  Successful treatment of severe intra‐abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII , 2001, British journal of haematology.

[14]  R. Porte,et al.  REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION: A Pilot Study , 2001, Transplantation.

[15]  J. Texier,et al.  Evaluation of Doppler examination for diagnosis of catheter-related deep vein thrombosis , 2004, Intensive Care Medicine.

[16]  D. Cabrol,et al.  [Practical use of sulprostone in the treatment of hemorrhages during delivery]. , 1995, Journal de gynecologie, obstetrique et biologie de la reproduction.